Best KDIGO Communications Podcasts (2025)

1
Episode 23: A Patient and Caregiver Perspective 12:15

Play Pause

17d ago12:15

12:15

What does life with a rare kidney disease really look like? Marianne Silkjaer Nielsen (Founder of CompCure, Denmark) offers a powerful voice for patients and caregivers. She reflects on the long diagnostic journey, the challenges of managing rare kidney disease, and the need for better awareness, advocacy, and international registries to improve ou…

1
Episode 22: Advancing Research and Novel Therapies for C3G 23:15

11d ago23:15

23:15

What does the future of treatment for C3 Glomerulopathy (C3G) look like? Dr. Nicole van de Kar (Radboud University Medical Center, The Netherlands) unpacks the pathophysiology of C3G, from genetic and autoantibody factors to the central role of the alternative pathway. She explores the limits of current C5 therapies and the potential of new strateg…

1
Episode 21: Diagnosis and Management of C3G 15:45

14d ago15:45

15:45

How do patients with C3 Glomerulopathy (C3G) present, and why is confirming the diagnosis so complex? Dr. David Kavanagh (National Renal Complement Therapeutics Centre, United Kingdom) walks through the diagnostic process, the shortcomings of traditional immunosuppression, and the promise of emerging therapies like alternative pathway inhibitors. H…

1
Episode 20: The Role of Complement in Kidney Diseases 19:45

9d ago19:45

19:45

Why does it matter if a kidney disease is complement-driven or complement-associated? Dr. Matthew Pickering (Imperial College London, United Kingdom) explains this critical distinction and why it changes how clinicians approach diagnosis and treatment. The discussion explores promising new therapies such as C3 and C5 inhibitors and how biomarkers a…

1
Episode 19: Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices 11:00

1+ y ago11:00

11:00

Episode 19 is the third episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu and Dr. Claudio Ronco (International Renal Research Institute of San Bortolo Hospital, Italy) discuss recent advancements and best practices sur…

1
Episode 18: Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI 11:30

1+ y ago11:30

11:30

Episode 18 is the second episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Kianoush Kashani (Mayo Clinic, United States) to discuss the rising importance of personalized care in AKI treatment. They del…

1
Episode 17: Stratifying the Risk of Persistent AKI and Clinical Practice 10:00

1+ y ago10:00

10:00

This is the first episode in KDIGO's new 3-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Jay Koyner (University of Chicago, United States) to discuss the emerging field of persistent acute kidney injury (AKI). They delve i…

1
Episode 16: Appropriate CKD Referral to Specialists 16:00

2y ago16:00

16:00

In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Ikechi Okpechi (University of Alberta, Canada) discuss the right time to refer patients with CKD to a nephrologist. This episode also addresses rapid CKD progression and the utility of risk prediction equations. This episode is supported by an independent educational grant …

1
Episode 15: Applying CKD Interventions 15:00

2y ago15:00

15:00

Join host Dr. Peter Lin (Canadian Heart Research Centre, Canada) in conversation with Dr. Joel Topf (Oakland University, William Beaumont School of Medicine, USA) as they discuss how to combat CKD progression and the role of non-pharmacological vs pharmacological interventions. This episode will explore whether foundational therapies are underused …

1
Episode 14: CKD Evaluation & Measurement 16:00

2y ago16:00

16:00

In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Magdalena Madero (National Heart Institute Mexico City, Mexico) discuss best practices for CKD evaluation and measurement. This episode focuses on the importance of assessing GFR and albuminuria, identifying the causes of CKD, CKD progression, and when more accurate GFR…

1
Episode 13: Early Detection of CKD 9:00

2y ago9:00

9:00

Join host, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Lekha Tummalapalli (Weill Cornell Medicine, United States) as they discuss the importance of early CKD detection. This episode explores risk factors, screening for CKD, and country specific factors to take into account when screening for CKD.This episode is supported by an in…

1
Episode 10: Challenges in the Early Diagnosis of AAV 12:30

2+ y ago12:30

12:30

Join host, Dr. Vladimir Tesar (General University Hospital, Prague), in conversation with Dr. Duvuru Geetha (Johns Hopkins University School of Medicine, United States) as they discuss the main causes of delays in diagnosis of ANCA-associated vasculitis and the different ways to increase awareness of the disease. This episode will also discuss the …

1
Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients 15:00

2+ y ago15:00

15:00

In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. David Jayne (Addenbrooke's Hospital, United Kingdom) discuss the roles of various agents in the induction and maintenance treatment of ANCA- associated vasculitis. They will explore the use of rituximab and complement inhibition in treating ANCA-associated vascul…

1
Episode 12: Is There Still Any Role for Plasma Exchange in AAV? 14:30

2+ y ago14:30

14:30

In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. Micheal Walsh (McMaster University, Canada) explore the benefits of plasma exchange for patients with ANCA-associated vasculitis. This episode discusses how to identify patients who may benefit from plasma exchange and the role of plasma exchange in patients with…

1
Episode 9: Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 16:30

3y ago16:30

16:30

Join host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), in conversation with Dr. Sandra Kane-Gill (University of Pittsburgh School of Pharmacy, United States) as they discuss the importance of drug stewardship when treating critically ill patients. This episode will examine various terms such as drug-induced acute kidney i…

1
Episode 8: The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients 21:30

3y ago21:30

21:30

In this episode, KDIGO Conversations in Nephrology host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), and Dr. Rinaldo Bellomo (University of Melbourne, Australia) will discuss the importance of hemodynamic stabilization in protecting kidney function for patients on kidney replacement therapy. This episode will also discuss…

1
Episode 7: Best Practices in Fluid Management During CKRT 21:30

3y ago21:30

21:30

Join host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), in conversation with Dr. Javier Neyra (University of Alabama in Birmingham, United States) as they explore the role of kidney replacement therapy in managing fluid overload. They will discuss optimal monitoring and how best to remove fluid safely and effectively, incl…

1
Episode 6: Management of Dyskalemias 20:00

4y ago20:00

20:00

Join KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Chuck Herzog as they explore the challenges that occur when managing dyskalemia. They address the consequences of hyperkalemia and hypokalemia. They also discuss how both hospitalized patients and outpatients are affected by hyperkalemia.Dr. Roberto Pec…

1
Episode 5: Approaches to RASi Optimization 12:30

4y ago12:30

12:30

Join KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Patrick Rossignol as they discuss approaches to RASi optimization. Additional topics include: Monitoring of creatinine and potassium What happens after? Is the GP responsible for follow-up? When to discontinue, when to return? Lack of communication betw…

1
Episode 4: Benefits of RASi Utilization 21:00

4y ago21:00

21:00

Join host, Dr. Roberto Pecoits-Filho, and Dr. Catherine Clase as they discuss the benefits of RASi utilization. Additional topics include: The role of RASi in the management of CKD progression Outcomes ACE / ARBs Is RASi underutilized? Is it worth not to discontinue? The impact of the KDIGO Blood Pressure Management in CKD Guideline and Diabetes Ma…

1
Episode 3: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement 12:54

4y ago12:54

12:54

Dr. Ravi Mehta and Theresa Mottes discuss which key components are needed when starting a quality improvement program (QI) for acute dialysis and why those components are needed. They also discuss how to get leverage to implement a QI program and the keys to a successful CRRT quality program.This episode was supported by Baxter.…

1
Episode 2: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use 15:44

4y ago15:44

15:44

Dr. Ravi Mehta and Dr. Ashita Tolwani discuss best practices on anticoagulation and citrate use, why circuit patency and integrity are important for CRRT, and how and when to use anticoagulation. They also discuss preferred methods for anticoagulation and the parameters that should be monitored for circuit integrity.This episode was supported by Ba…

1
Episode 1: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice 13:32

4y ago13:32

13:32

In this episode, Dr. Ravi Mehta and Dr. Marlies Ostermann discuss the controversy around defining the optimal timing for starting dialysis in critically ill patients. Dr. Osterman highlights the most relevant parameters that influence when to offer, start, and stop dialysis and gives a comprehensive review of the recent trials on the timing of dial…